To demonstrate that the creation of bifunctional T cells capable of recognizing two tumor antigens was possible using our transduction methods, T cell clone R6C12 cells were activated with anti-CD3 and anti-CD28 mAb then transduced to express the TIL 5 TCR. This evidence concerns the gene CD28 and neoplasm.